Cargando…

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identified by genome-wide analyses. Mutations in major PDAC driver genes were associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curia, Maria Cristina, Fantini, Fabiana, Lattanzio, Rossano, Tavano, Francesca, Di Mola, Francesco, Piantelli, Mauro, Battista, Pasquale, Di Sebastiano, Pierluigi, Cama, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518703/ https://www.ncbi.nlm.nih.gov/pubmed/31088413 http://dx.doi.org/10.1186/s12885-019-5616-2

Ejemplares similares

Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants
por: LATTANZIO, ROSSANO, et al.
Publicado: (2016)

Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids
por: VESCHI, SERENA, et al.
Publicado: (2012)

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma
por: Mazza, Tommaso, et al.
Publicado: (2017)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients
por: Tavano, Francesca, et al.
Publicado: (2014)

Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition
por: Aceto, Gitana Maria, et al.
Publicado: (2015)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
por: Du, Xingyi, et al.
Publicado: (2023)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
por: Ye, Zhihua, et al.
Publicado: (2022)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017)

PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021)

A Unique Four-Hub Protein Cluster Associates to Glioblastoma Progression
por: Simeone, Pasquale, et al.
Publicado: (2014)

Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer
por: Grassilli, Silvia, et al.
Publicado: (2020)

Correction: mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin
por: Guerra, Emanuela, et al.
Publicado: (2013)

mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin
por: Guerra, Emanuela, et al.
Publicado: (2012)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
por: Han, Hailin, et al.
Publicado: (2018)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
por: Mohamed Abd-El-Halim, Yousra, et al.
Publicado: (2021)

Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022)

p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
por: Guerra, Emanuela, et al.
Publicado: (2016)

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome
por: Grassilli, Silvia, et al.
Publicado: (2018)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
por: Huo, Yanmiao, et al.
Publicado: (2015)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2018)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020)

Low expression of tRF‐Pro‐CGG predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Li, Jun, et al.
Publicado: (2021)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Yamakawa, Kohei, et al.
Publicado: (2022)

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020)

Relationship between MUTYH, OGG1 and BRCA1 mutations and mRNA expression in breast and ovarian cancer predisposition
por: Moscatello, Carmelo, et al.
Publicado: (2021)

Integrative Analysis of Hereditary Nonpolyposis Colorectal Cancer: the Contribution of Allele-Specific Expression and Other Assays to Diagnostic Algorithms
por: De Lellis, Laura, et al.
Publicado: (2013)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Wang, Di, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021)

Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
por: Zong, Meijuan, et al.
Publicado: (2011)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Hang, Junjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_81r1pgj2paugphpu1l1rbu6p8a